Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19-guided antiplatelet treatment versus newer P2Y12 inhibitors in STEMI patients undergoing primary PCI
2010-024667-40Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor, prasugrel and clopidogrel in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Primary efficacy endpoint. Started Apr 2011; status: completed.
02
Drugs
ticagrelorprasugrelclopidogrel
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2010-024667-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024667-40.